Allergan (AGN) Tops Q4 EPS by 65c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Allergen (AGN) PT Raised to $203 at RBC Capital
February 10, 2020 11:45 AM ESTRBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $203.00 (from $197.00) while maintaining a Sector Perform rating.
Strong 4Q results provide encouraging read- through to ABBV/AGN proforma outlook... More


